CL
CLDWW
Calidi Biotherapeutics, Inc.
No data for this timeframe.
Vol
Inst. Holders6 funds
Inst. Value$17.1K
SEC Reports2
Recent Activity
May 29, 2026
SEC
Calidi Biotherapeutics issued an amended and restated warrant to purchase up to 17,391,304 shares of common stock at $0.
8-K — Impact 4/10
May 8, 2026
SEC
Calidi Biotherapeutics issued a warrant to an accredited investor to purchase up to 17,391,304 shares at $0.23 per share
8-K — Impact 4/10
Latest Reports
NEUTRAL
8-K
4/10
Calidi Biotherapeutics issued an amended and restated warrant to purchase up to 17,391,304 shares of common stock at $0.
May 29, 2026
NEUTRAL
8-K
4/10
Calidi Biotherapeutics issued a warrant to an accredited investor to purchase up to 17,391,304 shares at $0.23 per share
May 8, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC | $9.3K | — |
| NOMURA HOLDINGS INC | $6.1K | — |
| CITADEL ADVISORS LLC | $926.00 | — |
| Walleye Capital LLC | $478.00 | — |
| Walleye Trading LLC | $263.00 | — |
6 institutional holders with $17.1K total value (1,350,438 shares) as of 2024-Q3. Top holders: DRIEHAUS, NOMURA, CITADEL.
Top Institutional Holders — 2024-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | DRIEHAUS CAPITAL MANAGEMENT LLC | 750,000 | $9.3K | 54.3% | — |
| 2 | NOMURA HOLDINGS INC | 467,818 | $6.1K | 35.5% | — |
| 3 | CITADEL ADVISORS LLC | 70,701 | $926.00 | 5.4% | — |
| 4 | Walleye Capital LLC | 36,469 | $478.00 | 2.8% | — |
| 5 | Walleye Trading LLC | 20,052 | $263.00 | 1.5% | — |
| 6 | UBS Group AG | 5,398 | $70.00 | 0.4% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.